Stoehr Gerhard A, Sobh Julian N, Luecken Jan, Heidemann Kathrin, Mittler Uwe, Hilgers Reinhard, Eber Stefan W
Department of General Surgery, Georg August University, Goettingen, Germany.
Br J Haematol. 2006 Mar;132(6):791-3. doi: 10.1111/j.1365-2141.2005.05956.x.
We prospectively studied the efficacy of near total splenectomy (NTS) for managing hereditary spherocytosis (HS) based on haemoglobin (Hb), total bilirubin and splenic remnant regrowth in 30 children receiving NTS for HS between November 1996 and December 2004 (mean followup 3.6 years). Patients were classified into three severity groups. At followup, mean Hb had increased by 2.9-5.0 g/dl (P = 0.110) and bilirubin dropped by 15.4-56.4 mumol/l. Remnant regrowth was moderate, within the weight-specific norm. Amongst spleen-preserving techniques, NTS shows markedly lower rates of recurrent haemolysis, remnant regrowth and secondary operations, thus potentially benefiting all clinical forms of HS.
我们前瞻性地研究了近全脾切除术(NTS)治疗遗传性球形红细胞增多症(HS)的疗效,该研究基于1996年11月至2004年12月期间30例接受NTS治疗HS的儿童的血红蛋白(Hb)、总胆红素和脾残余再生情况(平均随访3.6年)。患者被分为三个严重程度组。随访时,平均Hb升高了2.9 - 5.0 g/dl(P = 0.110),胆红素下降了15.4 - 56. μmol/l。残余脾再生程度中等,在体重特异性正常范围内。在保留脾脏的技术中,NTS显示复发性溶血、残余脾再生和二次手术的发生率明显较低,因此可能使HS的所有临床类型受益。